Cite
HARVARD Citation
Van Cutsem, E. et al. (2020). Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study. European journal of cancer. pp. 150-157. [Online].